ESR1 and triple-negative breast carcinoma: Moreover, our studies have indicated that genistein, a soybean isoflavone, is instrumental in the reactivation of estrogen receptor α (ERα) in triple-negative breast cancer cells, which enhanced the efficacy of hormone therapy in these cells [8].